No Data
No Data
Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s (SZSE:002675) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?
Deng Xiaofeng newly invested in a resource stock.
Private equity tycoons Feng Liu and Deng Xiaofeng's latest holdings are here! In the third quarter, Feng Liu's managed Gaoyi Linshan No. 1 Yuanwang Fund entered the top ten list of tradable shareholders of 10 A-share companies, with a total market cap of approximately 19.538 billion yuan. Specifically, in the third quarter, Feng Liu increased his holdings in Beijing Tongrentang, Yantai Dongcheng Biochemicals, and Jonjee Hi-Tech Industrial and Commercial Holding; reduced his holdings in Angel Yeast Co., Ltd. and Nanjing King-Friend Biochemical Pharmaceutical; maintained his position unchanged in Hangzhou Hikvision Digital Technology, LB Group Co., Ltd., Shengyi Technology, Xinxiang Richful Lube Additive, and Shanghai Titan Scientific Co., Ltd. Deng Xiaofeng's managed Gaoyi Xiaofeng No. 2 Fund entered the top ten list of tradable shareholders of 13 A-share companies in the third quarter, with a total market cap of approximately 7.917 billion yuan. Gaoyi Xiaofeng Hongyuan Fund
Private Equity tycoons Feng Liu and Deng Xiaofeng's latest heavy-holdings stocks are here!
Deng Xiaofeng is reducing holdings
Dongcheng Pharmaceutical Unit Receives 20 Million Yuan in Government Grants
Yantai Dongcheng Biochemicals (002675.SZ): A wholly-owned subsidiary has received a government subsidy of 20 million yuan.
Gelonghui November 5th | Yantai Dongcheng Biochemicals (002675.SZ) announced that on November 4, 2024, Dongcheng Medical received a government subsidy of 20 million yuan from the Muping District Finance Bureau of Yantai City.
Dongcheng Pharmaceutical: Report for the third quarter of 2024
No Data
No Data